MICROTECH MED-B News

Weitai Medical-B (2235.HK): Continued expansion of core products R&D projects are progressing steadily

中信建投證券Oct 2, 2023 00:00

Weitai Medical-B-B (02235.HK): Continued optimization of gross margin and significant progress in R&D registration

中信證券Sep 12, 2023 16:02

Weitai Medical-B (02235.HK): CGM business was affected by the epidemic in the first half of the year, and is expected to recover in the second half of the year

微泰醫療Sep 30, 2022 17:40

Weitai Medical-B (02235.HK): Growth continues under the influence of the epidemic and commercialization process accelerates at home and abroad

中信證券Sep 1, 2022 00:00

Weitai Medical-B (02235.HK) Investment Value Analysis Report: Technology first, broad market, advanced diabetes management

中信證券Aug 4, 2022 00:00

Weitai Medical-B (02235.HK): Core product indications further expand and actively promote research and development

中金公司May 21, 2022 00:00

Weitai Medical-B (2235.HK): Rapid revenue growth, CGM products start domestic commercialization

中信建投證券Mar 28, 2022 14:32

MicroTech Medical (2235.HK): Strong recovery for patch pump in FY21; Focus on commercialization ramp up of CGMS; Buy

高盛Mar 28, 2022 00:00

Weitai Healthcare (2235.HK): Revenue grew rapidly, CGM products began domestic commercialization

中信建投證券Mar 28, 2022 00:00

MicroTech Medical (2235.HK) : Reshaping diabetes management technologies with a global footprint; initiate at Buy

高盛Nov 21, 2021 00:00

Weitai Healthcare (2235.HK): Digital transformation, leader in personal blood sugar management

中金公司Nov 21, 2021 00:00

Weitai Healthcare: CGM products approved for marketing, leading blood sugar management devices can be expected to grow

中信建投Nov 5, 2021 10:58

Weitai Medical-B (2235.HK) IPO Review: Pioneer of Adhesive Insulin Pumps

安信國際Oct 7, 2021 00:00

Weitai Healthcare (2235.HK) IPO Report: Rating: 69 Rating: Neutral

中泰國際Oct 6, 2021 00:00

IPO Preview: Weitai Medical-B (2235.HK)

光大新鴻基Oct 6, 2021 00:00